Neurotechnologies: Current Developments, Applications and Ethical Issues: Part one
The Research & Innovation Committee at the IoPPN (KCL) organises annual conferences exploring novel methodological and translational approaches changing the face of neurobiological research from bench to bedside.
This year’s event “Neurotechnologies: Current Developments, Applications and Ethical Issues” showcased the potential of new neurotechnological inventions (ranging from stem cell therapies, over deep brain stimulation to AI and human-technology symbiosis) in diagnosis and treatment of neurological and psychiatric conditions. Our speakers, included keynotes by Professors Viviane Tabar, Ed Boyden and Dustin Tyler, also presented the cutting-edge methodological innovations revolutionising neurobiological research and discussed the ethical issues surrounding their application.
Chairs: Professor Mitul Mehta and Dr Marija Petrinovic
An overview of the UK neurotechnology landscape
Charlie Winkworth-Smith, Knowledge Transfer Manager Technologies, UK
Optimization of trans cranial electrical stimulation
Michael Nitsche, Head of Department Psychology and neurosciences, Leibniz research centre for working environment and human factors, IfADo, Germany
Virtual Reality in Mental Health
Lucia Valmaggia, Reader in Clinical Psychology and Digital Mental Health, Head of Virtual Reality Lab, King’s College London, UK
Stem cell-based models of neuromuscular diseases
Ivo Lieberam, Reader, Centre for Developmental Neurobiology, King’s College London, UK
Nanoparticle Mediated Thermal Disruption of Fibrillary Beta-Amyloid Protein, Implications for Neurodegenerative Disease Therapeutics
Eric Dyne, Kent State University, Kent Ohio, USA
Pluripotent cells and the future of clinical neuroscience
Jack Price, Professor of Developmental Neurobiology, King’s College London, UK
The Research & Innovation Committee at the IoPPN (KCL) organises annual conferences exploring novel methodological and translational approaches changing the face of neurobiological research from bench to bedside.
This year’s event “Neurotechnologies: Current Developments, Applications and Ethical Issues” showcased the potential of new neurotechnological inventions (ranging from stem cell therapies, over deep brain stimulation to AI and human-technology symbiosis) in diagnosis and treatment of neurological and psychiatric conditions. Our speakers, included keynotes by Professors Viviane Tabar, Ed Boyden and Dustin Tyler, also presented the cutting-edge methodological innovations revolutionising neurobiological research and discussed the ethical issues surrounding their application.
Chairs: Professor Mitul Mehta and Dr Marija Petrinovic
An overview of the UK neurotechnology landscape
Charlie Winkworth-Smith, Knowledge Transfer Manager Technologies, UK
Optimization of trans cranial electrical stimulation
Michael Nitsche, Head of Department Psychology and neurosciences, Leibniz research centre for working environment and human factors, IfADo, Germany
Virtual Reality in Mental Health
Lucia Valmaggia, Reader in Clinical Psychology and Digital Mental Health, Head of Virtual Reality Lab, King’s College London, UK
Stem cell-based models of neuromuscular diseases
Ivo Lieberam, Reader, Centre for Developmental Neurobiology, King’s College London, UK
Nanoparticle Mediated Thermal Disruption of Fibrillary Beta-Amyloid Protein, Implications for Neurodegenerative Disease Therapeutics
Eric Dyne, Kent State University, Kent Ohio, USA
Pluripotent cells and the future of clinical neuroscience
Jack Price, Professor of Developmental Neurobiology, King’s College London, UK
